Cost-effectiveness of pazopanib compared with sunitinib in metastatic renal cell carcinoma in Canada. [electronic resource]
Producer: 20160818Description: e340-54 p. digitalISSN:- 1198-0052
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.